Table 6 Indications for operations in women with elective CSs
From: Lithuania’s experience in reducing caesarean sections among nulliparas
Indication | Absolute contribution to the CS rate in group 2B, %, 2012 | Absolute contribution to the CS rate in group 2B, %, 2014 | p value | Absolute contribution to the overall CS rate, %, 2012 | Absolute contribution to the overall CS rate, %, 2014 | p value |
|---|---|---|---|---|---|---|
Placental and umbilical cord pathology | 9.8 20/204 | 10.4 11/106 | p = 0.873 | 0.6 20/3626 | 0.3 11/3502 | p = 0.129 |
Fetus related conditions | 16.2 33/204 | 11.3 12/106 | p = 0.25 | 0.9 33/3626 | 0.3 12/3502 | p = 0.003 |
Maternal diseases | 48.0 96/204 | 49.0 52/106 | p = 0.741 | 2.7 96/3626 | 1.5 52/3502 | p < 0.001 |
Suspected fetal macrosomia | 6.9 14/204 | 9.4 10/106 | p = 0.424 | 0.4 14/3626 | 0.3 10/3502 | p = 0.465 |
Preeclampsia | 3.4 7/204 | 4.7 5/106 | p = 0.575 | 0.2 7/3626 | 0.1 5/3502 | p = 0.603 |
Post-term pregnancy | 16.7 34/204 | 15.1 16/106 | p = 0.719 | 0.9 34/3626 | 0.5 16/3502 | p = 0.015 |
Total | 5.6 204/3626 | 3.0 106/3502 | p < 0.001 |